# EPL Q2 profit rises 4%, beauty arm overtakes oral care 2026-11-05T09:08:28+00:00 | Governance | Indian Opinion Desk Corroboration: 2 independent outlets EPL reported a 4.52% rise in consolidated net profit to Rs 110.9 crore for the quarter ended 30 September 2026, with revenue climbing 30% year-on-year to Rs 1,567.4 crore. Underlying EBITDA margin stood at 20.4%. CEO Hemant Bakshi said beauty and cosmetics overtook oral care as the company's largest category during September, after recording over 40% growth in the quarter. EPL gained 130 basis points of global market share in beauty over the past year. The company is awaiting NCLT approval for its proposed Indovida merger, which is expected to close around April 2027. It targets $35 to 50 million in merger synergies over three years. Capital expenditure nearly doubled in the first half of FY27, directed at new manufacturing in China, Europe, India and a prestige line in the US. EPL reaffirmed near-term guidance of high-teens revenue growth and 20% underlying EBITDA margins. ## Indian Opinion Analysis Both outlets report EPL's Q2 FY27 results with nearly identical financial figures, Rs 111 crore net profit and Rs 1,567 crore revenue, and quote CEO Hemant Bakshi on the same milestones, such as beauty & cosmetics overtaking oral care in September 2026. CNBC-TV18 leads with the beauty segment's growth runway and the $35 to 50 million merger synergy target, giving deeper detail on capex and the Indovida merger timeline (April 2027). The Economic Times, while covering those points, front-loads the statutory profit figure and expenses line, and includes the stock's closing price. There is no conflict or slant: both take a neutral-report stance on straight financial reporting. The analysis difference is only in editorial selection: one emphasises the growth narrative, the other the quarterly scorecard. Neither overstates or omits material facts. The balanced takeaway is a company executing a diversified growth plan, with the NCLT decision for the Indovida merger as the next concrete event. ## Coverage Coverage: 2 sources, 2 neutral - cnbctv18.com (neutral report) Leads with growth runway and merger synergies - economictimes.indiatimes.com (neutral report) Leads with statutory profit and expenses detail This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Tags: EPL, Hemant Bakshi, Indovida, National Company Law Tribunal Canonical: https://indianopinion.org/epl-q2-profit-rises-4-beauty-arm-overtakes-oral-care/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/epl-q2-profit-rises-4-beauty-arm-overtakes-oral-care/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/